期刊名称：THERAPEUTIC DRUG MONITORING
|
ISSN： | 0163-4356
|
|
版本： | SCI-CDE
|
|
出版频率： | Bi-monthly
|
|
出版社： | LIPPINCOTT WILLIAMS & WILKINS, TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, USA, PA, 19103
|
|
出版社网址： | http://www.lww.com/
|
|
期刊网址： | http://www.drug-monitoring.com/
| |
影响因子： | 3.681 |
| 主题范畴： | MEDICAL LABORATORY TECHNOLOGY; PHARMACOLOGY & PHARMACY; TOXICOLOGY |
 期刊简介(About the journal)
投稿须知(Instructions to Authors)
编辑部信息(Editorial Board)
About the journal
Therapeutic Drug Monitoring
The journal is a peer-reviewed, multidisciplinary journal directed to an audience of pharmacologists, clinical chemists, laboratorians, pharmacists, drug researchers and toxicologists. It fosters the exchange of knowledge among the various disciplines¡ªclinical pharmacology, pathology, toxicology, analytical chemistry¡ªthat share a common interest in therapeutic drug monitoring. The journal presents studies detailing the various factors that affect the rate and extent drugs are absorbed, metabolized, and excreted. Regular features include review articles on specific classes of drugs, original articles, case reports, technical notes, and continuing education articles.
Therapeutic Drug Monitoring is an outstanding journal that fosters the exchange of knowledge among the various disciplines--clinical pharmacology, pathology, toxicology, analytical chemistry--that share a common interest in therapeutic drug monitoring. The journal presents studies detailing the various factors that affect the rate and extent drugs are absorbed, metabolized, and excreted. Regular features include review articles on specific classes of drugs; original articles; case reports; technical notes; and continuing education articles.
Instructions to Authors
Scope Therapeutic Drug Monitoring is a peer-reviewed, multidisciplinary journal directed to an audience of pharmacologists, clinical chemists, laboratorians, pharmacists, drug researchers and toxicologists. The Journal publishes Original Articles, Review Articles, Short Communications (no more than 10 manuscript pages or 3 printed pages in length and containing no more than 2 figures and 2 tables), Case Reports, Letters to the Editor (no more than 1 figure and 1 table), and selected abstracts from scientific meetings and conferences.
Manuscript Submission
A submitted manuscript is received with the understanding that it is an original contribution not previously published (except as an abstract or preliminary report), that it is not under consideration for publication elsewhere, and that, if accepted, it will not be published elsewhere in similar form, in any language, without the consent of Lippincott Williams & Wilkins. Each person listed as an author is expected to have participated in the study to a significant extent. Although the editors and referees make every effort to ensure the validity of published manuscripts, the final responsibility rests with the authors, not with the Journal, its editors, or the publisher.
Patient anonymity and informed consent: It is the author's responsibility to ensure that a patient's anonymity be carefully protected and to verify that any experimental investigation with human subjects reported in the manuscript was performed with informed consent and following all the guidelines for experimental investigation with human subjects required by the institution(s) with which all the authors are affiliated. Unless written consent is obtained and submitted with the manuscript, eyes should be masked and names should be removed from figures.
Copyright: A copy of the Journal's "Authorship Responsibility, Financial Disclosure, and Copyright Transfer" form must be signed by all authors and submitted to Dr. Koren or Dr. Oellerich at the address below.
Permissions: Direct quotations, tables, or illustrations that have appeared in copyrighted material must be accompanied by written permission for their use from the copyright owner (usually the publisher) and the original author, along with complete information as to the source.
Preparation of Manuscript
Manuscripts that do not adhere to the following instructions will be returned to the corresponding author for technical revision before undergoing peer review.
General format: Manuscripts should be submitted in English in triplicate (one original and two copies) and printed on standard 8½ ¡Á 11-inch (21 ¡Á 28-cm) paper with at least a 1-inch (2.5 cm) margin on all sides. All copy including legends, footnotes, tables, and references should be double-spaced and printed on one side of the sheet only. Materials prepared on a word processor computer should be printed with a letter-quality printer. On acceptance for publication, a disk containing the final accepted version of the manuscript will be requested.
Title page: The title page should contain (a) complete manuscript title; (b) authors' full names and affiliations; (c) name and address for correspondence, including fax number, telephone number, and e-mail address; (d) address for reprints if different from that of corresponding author; and (e) sources of support that require acknowledgment.
Unstructured abstract and key words: Limit the abstract to 2000 characters (including word spaces). It must be written in the third person; e.g.: "The authors tested a sample . . ." rather than "We tested a sample . . ." It must be factual and comprehensive. Limit the use of abbreviations and acronyms, and avoid general statements (e.g., "the significance of the results is discussed"). List three to five key words or phrases.
Text: The manuscript should be divided into four main headings: Materials and Methods, Results, Discussion, and Conclusion. Abbreviations must be defined at first mention in text and in each table and figure. If a brand name is cited, manufacturer and address (city and state/country) should be supplied. All forms of support, including pharmaceutical industry support, must be acknowledged in the Acknowledgment section.
Abbreviations: For a list of standard abbreviations, consult the Council of Biology Editors Style Guide (available from the Council of Science Editors, 9650 Rockville Pike, Bethesda, MD 20814) or other standard sources. The full term for which an abbreviation stands should precede its first use unless it is a standard unit of measure.
References: The authors are responsible for the accuracy of the references. References should be typed (double-spaced) at the end of the manuscript. They should be cited in the text in the order of appearance. Unpublished data (papers submitted but not yet accepted for publication, personal communications) should be cited parenthetically in text. If there are more than three authors, references should contain the names of the first three authors and be followed by et al. For abbreviations of journal names, refer to the List of Journals Indexed in Index Medicus for abbreviations of journal names, or access the list by clicking here Index Medicus. Sample references are given below:
Journal article
9. Shiffman ML, Luketic VA, Sanyal AJ, et al. Use of hepatic lidocaine metabolism to monitor patients with chronic liver disease. Ther Drug Monit 1996;18:372¨C7.
Book chapter
1. Burke M and Preskorn S. Short Term Treatment of Mood Disorders with Standard Antidepressants. In: Bloom F and Kupfer D, eds. Psychopharmacology: The Fourth Generation of Progress. New York: Raven Press; 1995:1060¨C1061.
Entire book
1. Bloom F and Kupfer D, eds. Psychopharmacology: The Fourth Generation of Progress. New York: Raven Press; 1995:1060¨C1061.
Software
1. Epi Info [computer program]. Version 6. Atlanta: Centers for Disease Control and Prevention; 1994.
Online journals
2. Friedman SA: Preeclampsia: a review of the role of prostaglandins. Obstet Gynecol [serial online]. January 1988;71:22¨C37. Available from: BRS Information Technologies, McLean, VA. Accessed December 15, 1990.
Database
3. CANCERNET-PDQ [database online]. Bethesda, MD: National Cancer Institute, 1996. Updated March 29, 1996.
World Wide Web
4. Gostin LO: Drug use and HIV/AIDS [JAMA HIV/AIDS web site]. June 1, 1996. Available at: http://www.ama-assn.org/special/hiv/ethics. Accessed June 26, 1997.
URL (uniform resource locator)
8. (J. M. Kramer, K. Kramer [jmkramer@umich.edu], e-mail, March 6, 1996).
Figures: Figures must be cited consecutively in the text and numbered in the order in which they are discussed. The first author's last name, the figure number and figure part (1A, 1B, 1C), and an arrow to indicate the top edge of the figure should be on a label pasted to or written on the back of each figure. All artwork should be submitted in triplicate in camera-ready form; illustrations should be glossy prints or high-quality, laser-printed illustrations. Photocopies are unacceptable. Lettering should be large enough that it will remain legible after figure reduction; typewritten or unprofessional lettering is unacceptable. Figure parts (A, B, C) may be left unlabeled (but clearly marked on back) for professional placement by the Journal's printer.
Figure legends: Legends should be brief and specific, and they should appear after the references. Use of scale markers in the image is suggested for electron micrographs, and the type of stain used should be indicated.
Color figures: Color figures that will enhance the article may be submitted for publication. Author costs will be estimated on an individual basis. Authors will be offered the alternative of black-and-white conversion at no charge if they choose not to pursue color reproduction.
Digital figures: Electronic art should be created/scanned and saved and submitted as either a TIFF (tagged image file format), an EPS (encapsulated postscript) file, or a PPT (Power Point) file. Line art must have a resolution of at least 1200 dpi (dots per inch), and electronic photographs¡ªradiographs, CT scans, and so on¡ªand scanned images must have a resolution of at least 300 dpi. If fonts are used in the artwork, they must be converted to paths or outlines or they must be embedded in the files. Color images must be created/scanned and saved and submitted as CMYK files. All electronic art must be accompanied by high-resolution laser prints of the images. Files can be submitted on a 3½inch high-density disk, a CD-ROM, or an Iomega Zip disk. Please note that artwork generated from office suite programs such Corel Draw and MS Word and artwork downloaded from the Internet (JPEG or GIFF files) cannot be used.
Tables: Like figures, tables should be cited consecutively in the text and numbered in that order. Each should be typed on a separate sheet and must include the table title, appropriate column heads, and explanatory legends (including definitions of any abbreviations used). Tables should not be embedded within the body of the manuscript. They should be self-explanatory and should supplement, rather than duplicate, the material in the text.
Style: In general, style should be patterned after the American Medical Association Manual of Style (9th edition). Stedman's Medical Dictionary (27th edition) and Merriam Webster's Collegiate Dictionary (10th edition) should be used as standard references. Drugs and therapeutic agents should be referred to by their accepted generic or chemical names. The name should not be abbreviated. Code numbers should be used only when a generic name is not yet available. In that case, the chemical name and a figure giving the chemical structure of the drug is required. Copyright or trade names of drugs should be capitalized and placed in parentheses after the name of the drug. Names and locations (city and state in USA; city and country outside USA) of manufacturers of drugs, supplies, or equipment cited in a manuscript are required to comply with trademark law and should be provided in parentheses. Units of measure should be expressed in the metric system, and temperatures should be expressed in degrees Celsius. Conventional units should be written as SI units as appropriate.
Address for manuscript submission:
From North and South America, send the manuscript with a cover letter to:
Gideon Koren, MD
Division of Clinical Pharmacology/Toxicology
Hospital for Sick Children
555 University Avenue
Toronto, ON, M5G 1X8
CANADA
Tel: (416) 813-5781
Fax: (416) 813-7562
E-mail: tdm.journal@sickkids.ca
From all other regions, send the manuscript with a cover letter to:
Prof.Dr.med.Dr.h.c. Michael Oellerich
Director
Department of Clinical Chemistry/Central Laboratory
George-August-University Centre of Internal Medicine
Robert-Koch-Str. 40
37075 Göttingen
GERMANY
tel: +49 5 51 39 8561
fax: +49 5 51 39 8551
E-mail: moeller@med.uni-goettingen.de
Please submit electronically to the above e-mail address whenever possible.
After Acceptance
Disk submission: Lippincott Williams & Wilkins requires that authors submit an electronic version of the final accepted manuscript along with a printout of the final accepted manuscript. Electronic files should be submitted in a standard word processing format; Microsoft Word (or Corel WordPerfect) is preferred. Although conversions can be made from other word processing formats, the vagaries of the conversion process may introduce errors. Do not submit ASCII text files. Do not use automatic numbering or footnotes for references. The Journal does not assume responsibility for errors in the conversion of customized software, newly released software, and special characters. The preferred storage medium is a 3½-inch disk, which should be labeled with the author's name, platform (e.g.., Windows 98, MAC), software (e.g.., MS Word, WordPerfect), and version (e.g.., 6.0, 7.0, 9.7). Authors preparing manuscripts on Macintosh computers should not use the Fast Save option. Each submitted disk must be clearly labeled with the name of the author, item title, Journal title, word processing program and version, and file name used. The disk should contain only one file¡ªthe final version of the accepted manuscript.
Page proofs and corrections: Corresponding authors will receive electronic page proofs to check the copyedited and typeset article before publication. Portable document format (PDF) files of the typeset pages and support documents (eg, reprint order form) will be sent to the corresponding author by e-mail. Complete instructions will be provided with the e-mail for downloading and printing the files and for faxing the corrected page proofs to the publisher. Those authors without an e-mail address will receive traditional page proofs. It is the author's responsibility to ensure that there are no errors in the proofs. Changes that have been made to conform to journal style will stand if they do not alter the authors' meaning. Only the most critical changes to the accuracy of the content will be made. Changes that are stylistic or are a reworking of previously accepted material will be disallowed. The publisher reserves the right to deny any changes that do not affect the accuracy of the content. Authors may be charged for alterations to the proofs beyond those required to correct errors or to answer queries. Proofs must be checked carefully and corrections faxed within 24 to 48 hours of receipt, as requested in the cover letter accompanying the page proofs.
Reprints: Authors will receive a reprint order form that includes reprint costs. Reprint requests should be returned with the corrected proofs, if possible. Reprints are normally shipped 6 to 8 weeks after publication of the issue in which the item appears. Inquiries regarding reprints should be directed to Reprint Department, Lippincott Williams & Wilkins, 530 Walnut Street, Philadelphia, PA 19106.
Publisher's contact: Corrected page proofs, reprint order forms, color proofs, and any other related materials should be sent to Proof Manager, Therapeutic Drug Monitoring, The Sheridan press, 450 Fame Avenue, Hanover, PA 17331.
Manuscript Checklist (before submission) To top of page
Three copies of complete manuscript
Three sets of clearly labeled figures
Cover letter
Title page
Abstract
References double-spaced in AMA style
Corresponding author designated (in cover letter and on title page)
Permission to reproduce copyrighted materials or signed patient consent forms
Acknowledgments listed for grants and technical support
Materials packed in extra-strength envelope
Manuscript Authorship Responsibility, Assignment of Copyright, and Financial Disclosure form signed by each author
Disk and high-quality print of electronic art
Disk containing first version of manuscript and labeled with word processing program used
Editorial Board
EDITORS-IN-CHIEF
Prof. Steven J. Soldin, Ph.D., F.A.C.B., F.C.A.C.B.
Director of Clinical Chemistry
Department of Laboratory Medicine
Children's National Medical Center
Professor
Departments of Pediatrics and Pathology
The George Washington University School of Medicine
Director
Georgetown Clinical Research Center
Bioanalytical Core Laboratory
Professor
Department of Pharmacology Georgetown University
111 Michigan Avenue. N.W.
Washington. D.C. 20010-2970
Telephone: (202) 884-2096
Telefax: (202) 884 2007
E-mail: ssoldin@cnmc.org
REVIEWS EDITOR
David Holt
London Prof. Dr. med. Dr. h. c. Michael Oellerich
Director
Department of Clinical Chemistry/Central Laboratory
George-August-University Centre of Internal Medicine
Robert-Koch-Str. 40
D-37075 Göttingen. Germany
Telephone: +49 551 39 8661
Telefax: +49 551 39 8551
E-mail: moeller@med.uni-goettingen.de
EDITORIAL BOARD
Thomas Annesley
Ann Arbor
Victor Armstrong
Göttingen
David Back
Liverpool
Androniki E. Balant-Gorgia
Chene-Bourg
Pierre Baumann
Prilly-Lausanne
Finn Bengtsson, MD, PhD
Linköping
Julio Benitez
Badajoz
Meir Bialer
Jerusalem
Donald J. Birkett
Bedford Park
Lawrence Bowers
Indianapolis
Kim Brosen
Odense
Uwe Christians
Denver
Rune Dahlqvist
Umeå
Amitava Dasgupta
Houston
Kurt Dubowski
Oklahoma City
Michel Eichelbaum
Stuttgart
William Evans
Memphis
Albert Fraser
Halifax
David J. Freeman
London, Ontario
Risto Huupponen
Turku
Takashi Ishizaki
Tokyo
Peter Jatlow
New Haven
Roger Jelliffe
Los Angeles
Atholl Johnston
London Gideon Koren
Toronto
Tai C. Kwong
Rochester
Lynne Lennard
Sheffield
Mark W. Linder
Louisville
Stuart MacLeod
Hamilton, Ontario
Pierre Marquet
Limoges
Raymond Morris
Woodville
Graham Mould
Guildford
Kimberly L. Napoli
Houston
Paul Orsulak
Dallas
Koichi Otani
Yamagata
Gilles Paintaud
Tours
Emilio Perucca
Pavia
Amadeo J. Pesce
Cincinnati
Curt Peterson
Linköping
C. E. Pippenger
Grand Rapids
Alphonse Poklis
Richmond
Offie Porat Soldin
Washington, D.C.
Michael D. Reed
Cleveland
Nader Rifai
Boston
Jan H.M. Schellens
Amsterdam
Leslie M. Shaw
Philadelphia
Gillian Shenfield
St. Leonards
Olav Spigset
Trondheim
Edoardo Spina
Messina
Lee How Sung
Singapore
Irving Sunshine
Pepper Pike
Andrew Trull
Cambridge
Toshihiko Uematsu
Gifu
Donald R.A. Uges
Groningen
Roland Valdes
Louisville
J. Allister Vale
Birmingham
John N. van den Anker
Washington, D.C.
Ellen Vinge
Lund
Alexander A. Vinks
Cincinnati
Irving Wainer
Washington, D.C.
Philip D. Walson
Cincinnati
Ian D. Watson
Liverpool
Douglas Westerlund
Uppsala
David S. Wilkinson
Richmond
John Williams
Cardiff
John F. Wilson
Cardiff
John T. Wilson
Shreveport
Steven Wong
Milwaukee
Raymond L. Woosley
Washington, DC
Randall W. Yatscoff
Edmonton
Ester Zylber-Katz
Jerusalem
|
刊名字顺( Alphabetical List of Journals):
返回页首 